Wave of European Cannabis firms to list in 2020, analyst says

This post was originally published on this site
© Reuters. Wave of European Cannabis firms to list in 2020, analyst says© Reuters. Wave of European Cannabis firms to list in 2020, analyst says

By Julien Ponthus

LONDON (Reuters) – Up to five companies active in the cannabis industry could go public in 2020 in Europe, a continent whose stock markets have largely missed out on the North-American “pot stocks” frenzy, a leading industry analyst said on Thursday.

The legalization of cannabis, including for recreational use in Canada and a number of U.S. states, fueled a speculative “green rush” on Toronto and New York stock markets in early 2019, but this has faltered due to oversupply fears and uncertainties on U.S. regulations.

Shares in the sector are down more than 50% from their March highs, according to the alternative harvest ETF fund (P:), which tracks cannabis-related stocks.

“I think there will be 4 or 5 companies quoted in twelve months time”, Nikolaas Faes, an analysts for Bryan Garnier told Reuters on the sidelines of a cannabis industry conference.

Bryan Garnier and its competitor Canaccord Genuity are among the few investment houses actively seeking to become key players in the fast-growing industry and win mandates to advise on merger and acquisitions or rights issues.

There has been speculation that London-based medicinal cannabis company Emmac could go public. In 2019, Emmac took over GreenLeaf, a French hemp-based and cannabis healthcare company and Swiss cannabis-based health company Blossom.

A spokesman for Emmac said an IPO remained an option but no longer for the current calendar year.

Listings of cannabis firms in Europe are very rare and currently limited to the small capitalization segment.

Public offerings are made difficult due to a patchwork of regulations and policies regarding the medical and recreational use of cannabis, including CBD, a derivative of the plant reputed to ease anxiety without the high associated with THC, the main psychoactive agent in marijuana.

Faes argues that London’s lightly regulated AIM is a market place of choice for such listings.

“I think that AIM is doing great efforts to attract some of those companies”, he said.

AIM declined to comment.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment